<DOC>
	<DOCNO>NCT00521378</DOCNO>
	<brief_summary>A study design determine appropriate dos Oral HDV Insulin meal time .</brief_summary>
	<brief_title>A Single-Blind , Placebo-Controlled , Dose-Ranging Trial Oral HDV-Insulin Patients With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Patients must satisfy follow inclusion criterion include study : 1. male female age of18 65 year , inclusive ; 2. current diagnosis type 2 DM , currently manage oral hypoglycemic agent least 3 month ; 3. current physical examination reveals clinically significant abnormality ; 4. clinically significant abnormality vital sign ; 5. body mass index ( BMI ) &lt; 38 ; 6. glycosylated hemoglobin ( HbA1c ) &gt; 8 &lt; 12 ; 7. Cpeptide level &gt; 3 ng/mL ; 8. typical fast blood glucose level &lt; 200 mg/dl ( +/ 25 mg/dl ) ; 9. available entire study period , able willing adhere protocol requirement ; 10. female childbearing potential , must use reliable form birth control ; , 11. provide write informed consent prior admission study . 1. history presence significant cardiac , gastrointestinal , endocrine , neurological , liver , kidney disease , condition know interfere absorption , distribution , metabolism , excretion insulin ; 2. history drug alcohol dependency psychological disease ; 3. clinically significant illness 4 week prior admission study ; 4. require regular use medication interfere absorption and/or metabolism insulin ; 5. recent use ( within 48 hour ) medication interfere blood glucose analysis , i.e. , mannose , acetaminophen , dopamine , ascorbic acid , report alter glucoseoxidase type blood glucose analytical method ; 6. use Avandia Actos treat diabetes ; 7. participation clinical trial use investigational drug within 30 day prior admission study ; 8. use MAO inhibitor enzymeinducing enzymeinhibiting agent ( eg , phenobarbital carbamazepine ) within 30 day prior admission study ; 9. pregnant lactating ; 10. episode severe hypoglycemia seizure coma within past year ; 11. history ketoacidosis ; 12. acute illness within 2 week prior Screening ; , 13. elevate liver enzyme ( ALT , AST , alkaline phosphatase ) &gt; 1.5 time upper limit normal .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Type 1 Type 2 Diabetes</keyword>
</DOC>